Home > Listed Companies Info. > Main Board Companies

:::

:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

Code:

Industry:

Local/Foreign Company:

4168 GlycoNex Inc.

中文

Company Profile

Chairman

CEO

Spokesperson

Tel

Address

Date of Listing (Regular)

Tong-Hsuan Chang

Mei-Chun Yang

Roger Lu

(02)2697-4168

8F., No.97, Sec. 1, Xintai 5th Rd., Xizhi Dist.,New Taipei City 22175,Taiwan

2012/12/18

Industry

Main Business

Biotechnology and Medical Care

Marching into 2015, GlycoNex has possessed advanced and complete technology platform: 1.glycosphingolipid antigen production and identification 2.monoclonal antibody production 3.cancer drug screening 4.stable cell line production for monoclonal antibody 5.process development and downstream purification The development of monoclonal antibody cancer drug has made tremendous progress. The mAbs of GlycoNex's research have been successfully licensed to a renowned international pharmaceutical co. in 2009, and IND application is scheduled to be filed in 2015. GlycoNex also utilizes its expertise on monoclonal antibody to march into CRO business. The CRO-CMO strategic alliance has been formed in 2010 between GlycoNex and Mitsubishi Gas Chemical Company Inc (MGC).

Shr. Vol.	Highest	Lowest	Closed	Change	Transaction	TurnOver(%)	long margin balance (1,000shr.)	Short margin balance (1,000shr.)
Market Information ( 2024/04/19 )
329.09	26.15	25.00	25.40	-0.65	260	.00	3,672	0
Trading method	Fun purchase price or securities pneeded on T day	Announcement of Irregularity (2024/04/19)	TPEx measures adopted (2024/04/19)		With warrants	Can be shorted or margined?	Detail
Normal	N	N	N		N	Y	Today	History

Financial Reports
Cash Flows	Items
	Items	Amount (NT$ thousand)
	Cash flows from operating activities
	Cash flows from investing activities
	Cash flows from financing activities
Balance Sheets	Current assets
	Non-current assets
	Total assets
	Current liabilities
	Non-current liabilities
	Total liabilities
	Share capital
	Capital surplus
	Retained earnings
	Other equity interest
	Treasury shares
	Total equity attributable to owners of parent
	Non-controlling interests
	Total equity
	Book Value per share(NT$)
Comprehensive Income	Operating revenue
	Operating costs
	Gross profit from operations
	Operating expenses
	Net other income (expenses)
	Net operating income
	Non-operating income and expenses
	Profit before tax
	Tax expense
	Profit from continuing operations
	Profit from discontinued operations
	Profit
	Other comprehensive income
	Comprehensive income
	Basic earnings per share

Auditor's report on latest financial statements： auditor's report：

More detail:MOPS。

Foreign issuers’ information is disclosed in consolidated statements.

TOP

TPEx

Listed Companies

General Stock Board Listed Company Profile